Oritavancin

• CAS: 171099-57-3
• Catalog Number: ACM171099573
• Category: Other Products
• Molecular Weight: 1793.12
• Molecular Formula: C₈₆H₉₇Cl₃N₁₀O₂₆
• Synonyms: ORITAVANCIN;Oritavancin (LY333328);(4R)-22-O-(3-Amino-2,3,6-trideoxy-3-C-methyl-a-L-arabinohexopyranosyl)-N3-(p-(p-chlorophenyl)benzyl)vancomycin;(4R)-22-O-(3-Amino-2,3,6-trideoxy-3-C-methyl-alpha-L-arabino-hexopyranosyl)-N3-[(4-chloro[1,1-biphenyl]-4-yl)methyl]vancomycin;LY 333328;Orbactiv;Oritavancin (Lyophilized Powder For IV Infusion)

Custom Q&A

What is the molecular formula of oritavancin?

The molecular formula of oritavancin is C86H97Cl3N10O26.

What is the molecular weight of oritavancin?

The molecular weight of oritavancin is 1793.1 g/mol.

When was oritavancin first created?

Oritavancin was first created on July 4, 2007.

What is the primary role of oritavancin as described in the reference?

Oritavancin is an antibacterial drug and an antimicrobial agent used for the treatment of skin infections.

Who developed oritavancin?

Oritavancin was developed by The Medicines Company, which was acquired by Novartis.

When was oritavancin initially approved by the FDA?

Oritavancin was initially approved by the FDA in 2014.

What are the FDA approved products containing oritavancin?

The FDA approved products containing oritavancin are Kimyrsa and Orbactiv.

What is the mechanism of action of oritavancin?

The mechanism of action of oritavancin is as a Cytochrome P450 inhibitor.

What is the IUPAC name of oritavancin?

The IUPAC name of oritavancin is a long chemical name based on its molecular structure.

What are some synonyms for oritavancin?

Some synonyms for oritavancin include LY333328 and Chlorobiphenyl-chloroeremomycin.